“…Such parameters can be, e.g., beam settings, DVHs for target volumes and OARs, or full 3-D dose distributions. DVH prediction has been widely studied in recent years for most disease sites, e.g., head and neck [214], [226], [258], [272], [274], [281], prostate [210], [238], [251], [255], [264], [266]- [268], [270], [276], [281], upper GI [259], [265], [273], [280], lower GI [229], [254], [269], [277], [278], and breast [259], [262], [275]. A commercial software for DVH prediction is Varian RapidPlan.…”